Invention Grant
- Patent Title: GLP-1R agonists and uses thereof
-
Application No.: US16902807Application Date: 2020-06-16
-
Publication No.: US10954221B2Publication Date: 2021-03-23
- Inventor: Wenge Zhong , Wei Guo
- Applicant: QILU REGOR THERAPEUTICS INC.
- Applicant Address: CN Shanghai
- Assignee: QILU REGOR THERAPEUTICS INC.
- Current Assignee: QILU REGOR THERAPEUTICS INC.
- Current Assignee Address: CN Shanghai
- Agency: McCarter & English, LLP
- Agent Yu Lu; Wei Song
- Priority: WOPCT/CN2019/082381 20190412
- Main IPC: C07D405/14
- IPC: C07D405/14 ; C07D417/14 ; C07D471/04
Abstract:
The present disclosure provides compounds of Formula (I) and pharmaceutical compositions thereof, for use in, e.g. treating type 2 diabetes mellitus, pre-diabetes, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and cardiovascular disease.
Public/Granted literature
- US20200325121A1 GLP-1R AGONISTS AND USES THEREOF Public/Granted day:2020-10-15
Information query
